Analyst Price Targets — ELUT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 21, 2024 8:43 am | Frank Takkinen | Loop Capital Markets | $10.00 | $3.50 | StreetInsider | Aziyo Biologics Inc. (ELUT) PT Raised to $10 at Lake Street Capital Markets |
| May 10, 2024 8:11 am | Ross Osborn | Cantor Fitzgerald | $5.00 | $3.29 | TheFly | Elutia price target lowered to $5 from $6 at Cantor Fitzgerald |
| November 16, 2022 9:52 am | — | Truist Financial | $10.00 | $7.64 | Benzinga | Truist Securities Maintains Buy on Aziyo Biologics, Raises Price Target to $10 |
| November 14, 2022 9:11 pm | Matt O'Brien | Piper Sandler | $10.50 | $8.20 | TheFly | Aziyo Biologics price target raised to $10.50 from $9 at Piper Sandler |
Latest News for ELUT
GAITHERSBURG, Md., March 02, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, today announced the appointment of Pete Ligotti as Chief Commercial Officer.
GAITHERSBURG, Md., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its fourth quarter 2025 financial results after market close on Wednesday, March 11, 2026.
GAITHERSBURG, Md., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it has been Certified™ by Great Place to Work®, the leading organization that evaluates workplace culture through a standardized, anonymous employee survey methodology developed over 30 years of research.
Fourth quarter revenue up 16% year-over-year, $26.9M of secured debt eliminated, and total cash and escrowed proceeds of $44.3M at year-end GAITHERSBURG, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today provided a corporate update and outlined upcoming development milestones for NXT-41x, its next-generation…
Elutia Inc. (NASDAQ: ELUT - Get Free Report)'s stock price shot up 4.7% on Friday. The company traded as high as $0.7887 and last traded at $0.7230. 796,463 shares changed hands during mid-day trading, an increase of 46% from the average session volume of 544,170 shares. The stock had previously closed at $0.6905. Wall Street
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ELUT.
U.S. House Trading
No House trades found for ELUT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.